FAQs What should I track to measure progress on GLP-1 therapy
These compounds may increase inflammatory signaling, glutathione demand and liver workload
The study co-endpoints were the percentage change in weight (with the 10 mg and/or 15 mg dose) from the start of the study (baseline) and the percentage of participants with a weight loss of 5% or more at 72 weeks, compared to placebo
For many people, Mounjaro weight loss can be significant when the medicine is used alongside diet, physical activity and medical follow-up
While most attention focuses on appetite suppression and blood sugar regulation, these medications also influence liver health, insulin sensitivity, hydration status, inflammation, and overall metabolic function
Thymosin alpha-1 and thymopoietin demonstrate immune-modulating effects that may help alleviate some of the chronic inflammation associated with poor implantation